Skip to main content
ABT logo
ABT
(NYSE)
Abbott Laboratories
$103.56-- (--)
Loading... - Market loading

Abbott Laboratories (ABT) Balance Sheet

Assets, liabilities, and shareholders' equity with annual and quarterly data.

Abbott Laboratories Balance Sheet Analysis

Assets, liabilities, and stockholders equity in billions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Abbott Laboratories (ABT) - Annual data in billions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period EndingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Current Assets
Cash and Cash Equivalents8.527.626.909.889.806.843.863.849.41
Short-Term Investments0.420.350.380.290.450.310.280.240.20
Cash & Short-Term Investments8.947.977.2810.1710.257.154.144.099.61
Accounts Receivable7.936.936.576.226.496.415.435.185.25
Inventory6.496.196.576.175.165.014.323.803.60
Other Current Assets2.642.182.262.662.351.871.791.571.69
Total Current Assets26.0023.6622.6725.2224.2420.4415.6714.6320.15
Non-Current Assets
Property, Plant & Equipment (Net)12.9411.7311.2810.288.9610.138.977.567.61
Long-Term Investments0.920.570.800.770.901.030.930.900.88
Goodwill24.0423.1123.6822.8023.2323.7423.2023.2524.02
Intangible Assets5.536.658.8210.4512.7414.7817.0318.9421.47
Other Non-Current Assets17.300.315.984.925.212.422.101.892.12
Total Non-Current Assets60.7257.7650.5449.2150.9652.1152.2252.5456.10
Total Assets86.7181.4173.2174.4475.2072.5567.8967.1776.25
Current Liabilities
Accounts Payable4.244.204.304.614.413.953.252.982.40
Short-Term Debt3.311.501.332.480.750.461.680.210.71
Current Portion of Long-Term Debt0.001.501.082.270.750.000.000.000.00
Accrued Liabilities6.886.466.546.766.440.000.000.000.00
Other Current Liabilities8.381.167.738.067.397.145.705.535.49
Total Current Liabilities16.5014.1613.8415.4913.1111.9110.869.018.91
Non-Current Liabilities
Long-Term Debt11.7612.6814.5515.4717.3019.4317.4219.3627.21
Deferred Tax Liabilities1.960.511.221.841.392.152.132.062.01
Other Non-Current Liabilities3.733.394.784.743.696.066.186.027.02
Total Non-Current Liabilities17.4519.3620.5522.0426.0727.6425.7227.4436.24
Total Liabilities33.9433.5134.3937.5339.1739.5536.5936.4545.15
Stockholders' Equity
Common Stock25.5325.1524.8724.7124.4724.1523.8523.5123.21
Retained Earnings49.7847.2637.5535.2631.5327.6325.8524.5623.98
Accumulated Other Comprehensive Income-6.00-7.91-7.84-8.05-8.37-8.95-8.47-7.59-6.06
Treasury Stock17.1816.8415.9815.2311.820.000.000.000.00
Additional Paid-in Capital0.00-16.84-15.98-15.23-11.82-10.04-10.15-9.96-10.23
Minority Interest0.640.240.220.220.220.220.210.200.20
Shares Outstanding1.741.731.731.741.760.000.000.000.00
Total Stockholders' Equity52.7747.9038.6036.6935.8032.7831.0930.5230.90
Total Liabilities & Equity0.0081.4173.2174.4475.2072.5567.8967.1776.25

Frequently Asked Questions About Abbott Laboratories Balance Sheet

What is a balance sheet?

A balance sheet shows a company's financial position at a specific point in time. It lists total assets (what the company owns), total liabilities (what it owes), and stockholders' equity (the difference). The fundamental equation: Assets = Liabilities + Equity.

What is stockholders' equity?

Stockholders' equity represents the net value belonging to shareholders — total assets minus total liabilities. It includes retained earnings, common stock, and additional paid-in capital. Growing equity over time typically indicates a healthy, profitable business.

What is working capital?

Working capital is current assets minus current liabilities. It measures a company's ability to pay short-term obligations with short-term assets. Positive working capital indicates the company can cover its near-term debts; negative may signal liquidity risk.

What is ABT's debt level?

Review Abbott Laboratories's total long-term debt and short-term borrowings in the balance sheet table above. Compare debt to equity and total assets to assess leverage and financial risk.

What is book value per share?

Book value per share is total stockholders' equity divided by shares outstanding. It represents the accounting value per share if the company were liquidated. Comparing market price to book value gives the price-to-book (P/B) ratio — a key valuation metric.

These financial metrics are calculated using balance sheet data. Learn how each metric works and screen stocks by them.